Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_assertion type Assertion NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_head.
- NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_assertion description "[In logistic regression analysis, CAC progression was dramatically more likely in type 1 diabetic subjects not treated with ACE inhibitor/angiotensin receptor blocker who had the TT-ID-AA/AC genotype combination than in those with other genotypes (odds ratio 11.6 [95%CI 4.5-29.6], P < 0.0001) and was even stronger when adjusted for cardiovascular disease risk factors and the mean A1C (37.5 [3.6-388], P = 0.002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_provenance.
- NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_assertion evidence source_evidence_literature NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_provenance.
- NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_assertion SIO_000772 17327458 NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_provenance.
- NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_assertion wasDerivedFrom befree-2016 NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_provenance.
- NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_assertion wasGeneratedBy ECO_0000203 NP596254.RAGrCjtXbl5CTt-E9TOIeSkMx_yuchNafxjYADgYksTcM130_provenance.